The Valley Desk

NCT04620330 · Interventional trial

A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer

Overall registry status Completed

Phase 2

Conditions KRAS Activating Mutation, Non Small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov